#ProstateCancerCVDRisk
Cardiovascular outcomes among patients with castration-resistant prostate cancer: A comparative safety study using U.S. administrative claims data
- Analytics use case(s): Estimation (Comparative Cohort), Characterization
- Study type: Clinical Research
- Tags: prostate cancer, castration-resistant prostate cancer, antiandrogens, aberaterone, enzalutamide, cardiovascular, safety, heart failure, acute myocardial infarction, ischemic stroke
- Study lead: Mitchell M. Conover
- Study lead forums tag: [conovermitch]
- Study start date: 11/27/2019
- Study end date: 8/1/2021
- Publications: TBD
- Results explorer: -
This repository contains study specification and documentation for a comparative cohort study comparing initiators aberaterone and enzalutamide with respect to incidence of various cardiovascular safety events including heart failure, acute myocardial infarction, and ischemic stroke.